Posts by Admin BioAlps
CHF 400 Million for Digisanté, a programme to transform the Swiss Healthcare system
The Swiss Federal Council wants to start Digisanté, a programme for the digital transformation of the healthcare system. The aim is to facilitate the exchange of patient data, and to improve efficiency, treatment quality and patient safety. The Swiss healthcare system is good, but it is lagging behind when it comes to digitisation.…
Read MoreBioAlps Awards 2023
Dr. Hervé Bourlard receive the BioAlps Academia Award, and Dr. Igor Fish and Dr Nicolas Mermod receive the BioAlps Industry Award.
Read MoreAn implant to restore walking in Parkinson’s patients
Neuroscientists and neurosurgeons from EPFL/CHUV/UNIL, Inserm and the University of Bordeaux have designed a neuroprosthesis to correct the gait disorders associated with Parkinson’s disease. In a study published in Nature Medicine, the scientists detail the development process of the neuroprosthesis which enabled them to treat a first patient suffering from Parkinson’s disease, enabling him to…
Read MoreCancer Research: CHF 1.1 Million for Novochizol SA
Cancer: EPFL and Novochizol SA to collaborate on designing more efficient immunotherapies, with the support of Innosuisse, the Swiss Innovation Agency.
Read MoreDEBIOTECH, your local expert and partner for the development of medical devices
Debiotech is delighted to support catalysing innovation and advancing healthcare. The Swiss medtech company is proud to be part & contribute to BioAlps Networking Day 2023 on 9 November 2023 at Campus Biotech.
Read MoreLonza: 300 jobs in Visp for a new vaccine
Lonza’s Visp site is preparing to manufacture components of a vaccine to protect against pneumococcus. Hundreds of jobs are at stake. For Lonza, each day is different. After losing the contract to produce the active ingredients of the anti-Covid vaccine designed by Moderna, the company has just extended its collaboration with Californian company…
Read MoreHedera Dx Launches Blood Based Cancer Testing
Hedera Dx, a Vaud-based oncology company specializing in liquid biopsy testing, has unveiled a fully streamlined solution that allows hospitals to adopt liquid biopsy testing locally for their patients with minimal efforts. The solution is a combination of laboratory reagents and a software platform. Liquid biopsies provide rapid, precise, non-invasive ways of assessing…
Read MoreSOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca
The three companies will collaborate to address global inequalities in comprehensive cancer care, and to improve global access to advanced cancer testing and data, broadening access to cutting edge science SOPHiA GENETICS, a category-defining software company and a global leader in data-driven medicine, announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK),…
Read MoreA visit at Mecaplast Swiss
Over the decades, Mecaplast Swiss has extended its offering beyond plastic injection per-say. The company may collaborate as early as the design phase, up to shipping fully finished products to its clients across the globe. The new ISO 7 clean room strengthens the offer as it is mainly be dedicated to the post-injection operations, assembly, finishing and packaging to meet the fast-growing demand of the MedTech industry.
Read MoreHealthcare Konnect (HCK) and Coreline Europe GmbH start a partnership
Healthcare Konnect (HCK) and Coreline Europe GmbH start a new partnership to amplify the inherent value of diagnostic accuracy. Healthcare Konnect (HCK) is Geneva-based company that created a shared platform providing health organisations access to world-leading AI solutions to assist medical diagnostics. The HCK Hub, HCK’s propriety platform, routes anonymised patients’ data to…
Read More